| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:e15.)
© 2009 American Heart Association, Inc.
Case Reports |
From Department of Neurology (C.T., L.A.B.), Haukeland University Hospital, Bergen Norway; Department of Clinical Medicine (C.T., L.A.B.), University of Bergen. Bergen, Norway.
Correspondence to Charalampos Tzoulis, Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway. E-mail chtzoulis{at}yahoo.com or tzou@helse-bergen.no
| Abstract |
|---|
|
|
|---|
Methods— We performed 9 serial MRI covering 2 stroke-like episodes in a 36-year-old man with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode caused by the common mitochondrial DNA mutation 3243A>G.
Results— We found clear evidence of initial restricted diffusion in the stroke-like lesions, which gradually evolved to high-apparent diffusion coefficient as lesions aged. Evolution was, however, asynchronous with both high- and low-apparent diffusion coefficients temporally coexisting.
Conclusions— Our findings suggest that cytotoxic edema does occur early in the course of a stroke-like lesions and that its presence or, conversely, the absence of vasogenic edema, should not weaken the possibility of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episode in favor of ischemic stroke.
Key Words: brain imaging cerebral infarct diffusion-weighted imaging imaging mitochondria
| Introduction |
|---|
|
|
|---|
|
| Patients and Methods |
|---|
|
|
|---|
Nine MRI examinations were performed before, during, and after both stroke-like episodes. MRI was performed in a Siemens Magneton Symphony 1.5-T scanner with 30-mT/m gradients and a General Electric Sigma Excite 3-T HDX scanner with 40-mT/m gradients. Sequences included T1 (with and without gadolinium), T2, and T2 fluid-attenuated inversion recovery (FLAIR)-weighted. Diffusion imaging was performed with b values of 0, 500, and 1000; based on these, ADC maps were constructed.
| Results |
|---|
|
|
|---|
Three days later we found spatial progression of the lesion, which now involved most of the right occipital lobe. New lesions (1 to 3 days old) invariably exhibited low ADC, whereas several areas with previously low ADC had evolved to normal or high ADC. A small area of gyriform cortical T1 hyperintensity was now evident in the anterior part of the superior temporal gyrus, consistent with cortical laminar necrosis (Figures 1 and 2
).
|
|
MRI, performed 58 days after onset, showed significant regression of the lesion with atrophy and retraction. There was minor residual hyperintensity on DWI, whereas lesional ADC was uniformly increased. There was significant enlargement of the T1 gyriform cortical hyperintensity (Figures 1 and 2
). Imaging at 120 and 251 days and
2 and 3 years after the onset of stroke-like episode 1 showed progressive regression of the T2 hyperintensity and further focal atrophy with ex vacuo ventricular enlargement. DWI signal returned to baseline early, whereas the ADC remained, in parts, elevated 3 years after ictus. The T1 cortical hyperintensity gradually regressed and was only barely visible by 2 years (Figure 2).
Thirteen days after the clinical onset of stroke-like episode 2, MRI revealed a new cortical and subcortical T2 hyperintensity in the left temporal lobe. Diffusion findings were similar to those found in stroke-like episode 1, and again an inverse association was seen between the degree of DWI hyperintensity and ADC. T1 showed hypointensity, swelling, and sulcal effacement. Follow-up MRI 11 months later showed significant regression of the signal abnormalities and atrophy. DWI was isointense and, in parts, hypointense, whereas lesional ADC was normal and, in parts, high (Figure 2).
| Discussion |
|---|
|
|
|---|
Whereas the exact mechanism involved in SLLs are unknown, several theories have been proposed, including primary neuronal mitochondrial dysfunction causing direct energy insufficiency, vascular mitochondrial dysfunction leading to neuronal ischemia, and a unifying neurovascular mechanism.1 Irrespective of the primary pathogenic event, neurons within SLL are assumed to be energy-deprived and, from this, one would predict the occurrence of cytotoxic edema and restricted diffusion in the acute phase of the lesion.
Our findings suggest initial neuronal energy insufficiency causing cytotoxic edema and low ADC, and subsequent development of extracellular edema that gradually increases the ADC. As lesions expand and new areas become involved, the 2 processes overlap temporally, producing a mixture of cytotoxic and vasogenic edema and conversely low and high ADC.
The reason why ADC findings vary in reported SLL remains unknown, but one possible explanation is the time interval between stroke-like episode onset and MRI. All studies reporting low ADC have a short onset-MRI interval, and follow-up shows gradual ADC increase within days to weeks (Table).3,4,10 Some studies reporting normal or high ADC also have short intervals (Table).2,6–9 This apparent contradiction may, however, reflect the difficulties with precisely defining onset of a SLL. An SLL develops more slowly than ischemic stroke and may not initially produce symptoms severe enough to prompt medical attention. It is possible to speculate that in at least some of the cases reporting early increased ADC, the lesions may have already evolved over several days before clinical presentation.
In conclusion, our findings strengthen the view that cytotoxic edema does occur early in the course of a stroke-like episode. Therefore, its presence or, conversely, the absence of vasogenic edema, should not weaken the possibility of MELAS in favor of ischemic stroke. The distribution of the SLL, showing a predilection for the temporal, parietal, and occipital areas and spanning vascular borders, should alert the clinician to the possibility of SLL. Furthermore, in contrast to acute ischemic infarcts that show little, if any, spatial progression, SLL tend to evolve and expand in size during the first few days to weeks after onset.
| Acknowledgments |
|---|
None.
Received May 1, 2008; revision received June 24, 2008; accepted June 26, 2008.
| References |
|---|
|
|
|---|
2. Ohshita T, Oka M, Imon Y, Watanabe C, Katayama S, Yamaguchi S, Kajima T, Mimori Y, Nakamura S. Serial diffusion-weighted imaging in MELAS. Neuroradiology. 2000; 42: 651–656.[CrossRef][Medline] [Order article via Infotrieve]
3. Mizrachi IB, Gomez-Hassan D, Blaivas M, Trobe JD. Pitfalls in the diagnosis of mitochondrial encephalopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol. 2006; 26: 38–43.[Medline] [Order article via Infotrieve]
4. Bi WL, Baehring JM, Lesser RL Evolution of brain imaging abnormalities in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. J Neuroophthalmol. 2006; 26: 251–256.[Medline] [Order article via Infotrieve]
5. Jian-Ren L. Precipitation of stroke-like event by chickenpox in a child with MELAS syndrome. Neurol India. 2005; 53: 323–325.[Medline] [Order article via Infotrieve]
6. Yoneda M, Maeda M, Kimura H, Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology. 1999; 53: 2182–2184.
7. Oppenheim C, Galanaud D, Samson Y, Sahel M, Dormont D, Wechsler B, Marsault C. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry. 2000; 69: 248–250.
8. Yonemura K, Hasegawa Y, Kimura K, Minematsu K, Yamaguchi T. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol. 2001; 22: 269–272.
9. Kolb SJ, Costello F, Lee AG, White M, Wong S, Schwartz ED, Messé SR, Ellenbogen J, Kasner SE, Galetta SL. Distinguishing ischemic stroke from the stroke-like lesions of MELAS using apparent diffusion coefficient mapping. J Neurol Sci. 2003; 216: 11–15.[CrossRef][Medline] [Order article via Infotrieve]
10. Wang XY, Noguchi K, Takashima S, Hayashi N, Ogawa S, Seto H. Serial diffusion-weighted imaging in a patient with MELAS and presumed cytotoxic oedema. Neuroradiology. 2003; 45: 640–643.Epub 2003 Jul 25.[CrossRef][Medline] [Order article via Infotrieve]
11. Schaefer PW, Grant PE, Gonzalez RG Diffusion-weighted MR imaging of the brain. Radiology. 2000; 217: 331–345.
12. Hasegawa Y, Formato JE, Latour LL, Gutierrez JA, Liu KF, Garcia JH, Sotak CH, Fisher M. Severe transient hypoglycemia causes reversible change in the apparent diffusion coefficient of water. Stroke. 1996; 27: 1648–1656.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |